Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.
about
Hepatitis B virus: inactive carriersKASL clinical practice guidelines: management of chronic hepatitis BManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsEmerging hepatitis B virus infection in vaccinated populations: a rising concern?The clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsCurrent hepatitis B virus infection situation in Indonesia and its genetic diversityIs mother-to-infant transmission the most important factor for persistent HBV infection?A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations.Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestineA Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface AntigenHepatitis B virus and its sexually transmitted infection - an update.Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.High affinity mouse-human chimeric Fab against hepatitis B surface antigen.Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries.Cancer risks and prevention practices among Vietnamese refugees.Immunogenicity of hepatitis B virus vaccine (Heptavax-B)--response of healthy adultsPrevention of hepatitis B in infants born to HBsAg-carrier mothersCost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatmentUpdate on diagnosis, management, and prevention of hepatitis B virus infection.Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.Primary hepatocellular carcinoma following perinatal transmission of hepatitis B.Screening for hepatocellular carcinoma. Review and perspective.Hepatitis B in pregnancy.Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated AreaCost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.Sexually transmitted viral infections in various population groups in Mogadishu, Somalia.Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.Hepatitis B Therapy in PregnancyA program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women.Cancer burden and trends in the Asian Pacific Rim region.Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.Can we eradicate hepatitis B?Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.Strategies for hepatitis B immunisation.Epidemiology of hepatitis B infection in the Western Pacific and South East AsiaAge-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis.
P2860
Q24810833-625C68F3-B462-4734-8BFC-CFCBFFBDFC89Q26752475-54384B84-A723-4D95-99C5-C4A2E8AE3C51Q27008984-970F9B5E-DD5B-4F6C-95C3-82B1107CF1CBQ27012663-F5FBA8B4-C8DE-479E-B16D-63D452BD6040Q28073299-006CC4C3-B620-4C10-B597-A98C370573EDQ28074068-8BBA57DB-1069-4BE7-B269-2B8CB5CBAAAEQ28083160-B5AE8DE3-76A0-4AE5-87E8-5D5D66017713Q28319816-BDB09525-6309-4CDD-A1AE-242272EAA455Q28366618-B89C81D6-596C-4E52-B46D-5BF42FFE337AQ28542694-C9EB45F9-BE8E-4268-B105-900FBA2CD4EBQ30152118-8153CB29-44C8-4ACC-822B-DBE253E46CC3Q30235028-C1AF8786-9284-4604-BE37-F09D33C9DBFBQ30244568-BC258089-90DF-4760-A00C-0F2798ACDDC3Q33232511-5BAFA8F1-7D39-4068-AE0D-A18C7E21187EQ33318588-CAC6ED68-3E00-410C-AA76-0E3868109520Q33558369-5E87CC30-5256-4C20-8AF1-B6AB3FBF929AQ33581088-4C7CAE17-84A6-4E67-9676-D2A7962F8257Q33581265-C4D6CC4D-F2CD-43AC-B866-9017761E7228Q33587889-7571D235-2644-46F0-BC9B-BF2E8C17786BQ33588921-C962E7B2-4CFD-4DA8-8074-89768BF56590Q33606219-B1E44990-8A25-40CC-BCF3-476CBFC19B11Q33615334-0EE94255-27CD-456E-8EE3-69EF85B7F31DQ33616024-73D09694-A9A8-4FB8-B81C-B35127AB66EAQ33617002-C48C8FC5-15E2-43D7-AF98-50133DA529F1Q33682797-7621CF6B-2FE6-454A-B555-3011761923D6Q33701455-41F437DB-87B9-4494-800E-74855F0C6E3EQ33852768-E9AC692E-9B36-4103-A55C-5A64EFA98849Q33931401-4296EFC7-F041-45E1-8A38-E761B3E58618Q34067032-F464F087-251B-46C8-A38D-3A910DC27E39Q34154952-A1B84340-F370-4893-AF24-23FEC25A20F8Q34195174-D6F883E4-8A10-498B-99D4-3A7C368A0923Q34222138-15B8D8A5-A4C4-4477-83DD-768D56F9DC19Q34232555-201E6063-00CA-4DFA-94D6-21EFA9FB861EQ34288012-FC27FBD2-57B6-4138-B992-E579485FF528Q34343621-60F3DC12-F489-4EE9-8FC1-E93A1C2D9EA9Q34395230-F4910A95-21E9-4B08-8376-B4F155115A9BQ34441984-0F08B7EE-78EF-4C2A-940D-53D0A8281EF5Q34460388-9733F0E5-2950-4650-97FC-6D8108C05FA0Q34579821-96EE172C-9479-48E4-8501-C512DE356B5CQ34657327-E457C39A-91F4-49B2-96D6-41991CD104FD
P2860
Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@en
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@nl
type
label
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@en
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@nl
prefLabel
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@en
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@nl
P2093
P1433
P1476
Prevention of perinatally tran ...... bulin and hepatitis B vaccine.
@en
P2093
R P Beasley
P304
P356
10.1016/S0140-6736(83)90624-4
P407
P577
1983-11-01T00:00:00Z